A significant breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This essential cancer suppressor protein is frequently inactivated in several forms of tumors, leading https://socialeweb.com/story7450060/mini-antibodies-revive-tumor-suppressor-p53-a-promising-pathway-for-malignant-therapy